Intrinsic Alpha

Elevance Health Inc.

NYSE:ELV

Medical - Healthcare Plans

Healthcare
$394.48 -0.88%

-$3.45 today

Market cap
$85.23B
Beta
0.68
P/E (TTM)
16.3
EPS (TTM)
$23.78
Dividend yield
1.77%
52W Low $273.71High $426.98

Volume 2.04M

Average 1.68M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$4.29B

FY 2025 · Annual

-26.1% YoY

Investing Cash Flow

-$1.34B

FY 2025 · Annual

Financing Cash Flow

-$1.74B

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income6.1B6.02B5.99B5.97B5.66B
Depreciation & Amortization1.3B1.68B1.75B1.39B1.55B
Deferred Income Tax173M(76M)(602M)(374M)(279M)
Stock-Based Compensation255M264M289M191M276M
Change in Working Capital784M253M(535M)(1.72B)(3.28B)
Accounts Receivables(2.14B)(2.51B)(1.76B)(683M)(2.53B)
Inventory2.14B2.51B000
Accounts Payables719M252M1.64B(272M)(720M)
Other Working Capital65M1M(413M)(764M)(31M)
Other Non-Cash Items(245M)264M1.18B346M363M
Operating Cash Flow8.36B8.4B8.06B5.81B4.29B
Capital Expenditures(1.09B)(1.15B)(1.3B)(1.26B)(1.12B)
Acquisitions (Net)(3.48B)(649M)(1.55B)(4.45B)88M
Purchases of Investments(18.67B)(24.95B)(16.24B)(17.99B)(15.03B)
Sales of Investments14.61B22.61B13.54B18.57B15.1B
Other Investing Activities(1.02B)(421M)(24M)(51M)(385M)
Investing Cash Flow(9.64B)(4.56B)(5.57B)(5.17B)(1.34B)
Debt Repayment2.34B1.8B739M5.56B2.33B
Common Stock Issued00000
Common Stock Repurchased(1.9B)(2.32B)(2.68B)(2.9B)(2.61B)
Dividends Paid(1.1B)(1.23B)(1.4B)(1.51B)(1.53B)
Other Financing Activities1.08B432M(17M)39M69M
Financing Cash Flow423M(1.32B)(3.35B)1.19B(1.74B)
Effect of Forex Changes(10M)(14M)(1M)(72M)(5M)
Net Change in Cash(861M)2.51B(861M)1.76B1.2B
Free Cash Flow7.28B7.25B6.77B4.55B3.17B

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$5.7B
+ D&A$1.5B
+ Stock-Based Comp$276.0M
- Deferred Tax-$279.0M
- Working Capital-$3.3B
+ Other Non-Cash$363.0M
= Operating Cash Flow$4.3B
- Capex-$1.1B
= Free Cash Flow$3.2B

Analysis

FY2025 free cash flow is $3.2B. FCF conversion is 56.1% of net income. Operating cash flow was $4.3B, with capex of -$1.1B. The largest bridge item is Working Capital at -$3.3B.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipNov 6, 2026
S-3ASRS-3ASR filingOct 28, 2026
4Statement of changes in beneficial ownershipOct 23, 2026
8-KCurrent reportOct 21, 2026

Does ELV generate free cash flow?

Elevance Health Inc. (ELV) generated $3.17B of free cash flow in fiscal 2025.

How much operating cash flow does ELV produce?

Operating cash flow was $4.29B, before capital expenditures of $1.12B.